Doping of Germanium Surfaces - Licensing Opportunity from UCC April 2016 front page preview

Doping of Germanium Surfaces - Licensing Opportunity from UCC April 2016

The fundamental component of CMOS device technology is a doped or extrinsic semiconductor. Doping is a process whereby impurities are introduced into the crystal lattice of the semiconductor, creating charge carriers tha...

pdf 673.3KB

Bioblockers - Antifungal Biofilm Disruptors for Medical Devices - Licensing Opportunity from UCC April 2016 front page preview

Bioblockers - Antifungal Biofilm Disruptors for Medical Devices - Licensing Opportunity from UCC April 2016

Fungal infection can cause serious illness, especially in patients with compromised immune systems. UCC scientists have identified potent drug-like compounds capable of disrupting biofilm formation and growth; in particu...

pdf 148.3KB

Toddler Milk Technology Offer - Licensing Opportunity from Teagasc November 2017 front page preview

Toddler Milk Technology Offer - Licensing Opportunity from Teagasc November 2017

This invention relates to a process enabling the production of a novel natural reduced-fat, or full-fat, low-protein dairy product from cow’s milk, which has been tailored to meet a toddler’s typical nutritional needs. A...

pdf 58KB

Laser-textured Interference-fit Fasteners with Highly Controlled Bond Strength - Licensing Opportunity from Dublin City University - January 2016 front page preview

Laser-textured Interference-fit Fasteners with Highly Controlled Bond Strength - Licensing Opportunity from Dublin City University - January 2016

The invention is a novel, rapid laser micro-profiling technique for producing interference fit fasteners. In this technique, a high powered laser is used to alter the surface texture of a metal pin, to produce an interfe...

pdf 1.9MB

Novel companion diagnostic and  treatment for metastic breast cancer disease - Licensing Opportunity from Royal College of Surgeons in Ireland - November 2015 front page preview

Novel companion diagnostic and treatment for metastic breast cancer disease - Licensing Opportunity from Royal College of Surgeons in Ireland - November 2015

Endocrine therapies are the treatment of choice for over 70% of breast cancer patients, however 40% will relapse and develop metastatic disease. Metastasis is the prime cause of cancer patient mortality. There is curren...

pdf 383.4KB